Curated daily feed on Biotech for July 20, 2026: top articles, videos & insights.
On July 20, 2026, the focus in biotech centered on Colossal Biosciences, a de-extinction startup reportedly negotiating to raise new capital at a valuation between $20 billion and $30 billion. This indicates a significant interest and investment potential in biotechnology aimed at reviving extinct species, reflecting ongoing trends in the industry towards ambitious projects and high valuations. Readers can expect insights into the financial dynamics and future prospects of innovative biotech ventures.
1 item on this day.